{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:21:45Z","timestamp":1787800905023,"version":"build-2784847793"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"am","delay-in-days":240,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30 ES020957"],"award-info":[{"award-number":["P30 ES020957"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R00ES028734"],"award-info":[{"award-number":["R00ES028734"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011415","name":"Office of the Vice President for Research, Wayne State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK106540"],"award-info":[{"award-number":["R01DK106540"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jnutbio.2021.108633","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T11:19:29Z","timestamp":1616930369000},"page":"108633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-3130","authenticated-orcid":false,"given":"Zhao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4826-3400","authenticated-orcid":false,"given":"Katherine","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Petriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2021.108633_bib0001","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0003","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14336\/AD.2014.0305","article-title":"Metabolic syndrome, aging and involvement of oxidative stress","volume":"6","author":"Bonomini","year":"2015","journal-title":"Aging Dis"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1534-5807(02)00401-X","article-title":"The forkhead transcription factor Foxo1 regulates adipocyte differentiation","volume":"4","author":"Nakae","year":"2003","journal-title":"Dev Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0006","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.redox.2017.01.012","article-title":"Metabolic zonation of the liver: The oxygen gradient revisited","volume":"11","author":"Kietzmann","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.it.2014.03.006","article-title":"Gene regulatory networks in the immune system","volume":"35","author":"Singh","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrendo.2010.155","article-title":"PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis","volume":"6","author":"Kawai","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0009","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","article-title":"The Human Transcription Factors","volume":"172","author":"Lambert","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0011","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0012","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0013","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0014","first-page":"2099","article-title":"Diagnosis of nonalcoholic fatty liver disease (NAFLD)","volume":"132","author":"Yki-Jarvinen","year":"2016","journal-title":"Duodecim"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0016","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0017","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis","volume":"56","author":"Loomba","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0019","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0020","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0021","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0022","article-title":"Multiple Parallel Hits Hypothesis in NAFLD - Revisited After a Decade","author":"Tilg","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0023","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0024","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101072","article-title":"Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fgene.2019.00591","article-title":"The Role of Mammalian Creb3-Like Transcription Factors in Response to","volume":"10","author":"Khan","year":"2019","journal-title":"Nutrients. Front Genet."},{"key":"10.1016\/j.jnutbio.2021.108633_bib0027","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1096\/fj.201601227R","article-title":"Human leucine zipper protein promotes hepatic steatosis via induction of apolipoprotein A-IV","volume":"31","author":"Kang","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0028","doi-asserted-by":"crossref","first-page":"e1527","DOI":"10.1038\/cddis.2014.490","article-title":"Identification of Creb3l4 as an essential negative regulator of adipogenesis","volume":"5","author":"Kim","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0029","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1038\/nutd.2015.29","article-title":"Effects of low-fat diet and aging on metabolic profiles of Creb3l4 knockout mice","volume":"5","author":"Kim","year":"2015","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","article-title":"Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response","volume":"124","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0031","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/hep.22439","article-title":"Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H","volume":"48","author":"Luebke-Wheeler","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0032","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1194\/jlr.M045104","article-title":"Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH","volume":"55","author":"Xu","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0033","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.molmet.2016.09.004","article-title":"Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression","volume":"5","author":"Kikuchi","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0034","unstructured":"The Broad Institute of MIT and Harvard. GTEx portal. 2019."},{"key":"10.1016\/j.jnutbio.2021.108633_bib0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.24783","article-title":"Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice","volume":"55","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0036","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2013-1490","article-title":"Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21","volume":"155","author":"Kim","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0037","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.27371","article-title":"Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0038","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbrc.2009.12.046","article-title":"The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha","volume":"391","author":"Danno","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0039","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmet.2010.02.016","article-title":"Regulation of hepatic gluconeogenesis by an ER-bound transcription factor","volume":"11","author":"Lee","year":"2010","journal-title":"CREBH. Cell Metab."},{"key":"10.1016\/j.jnutbio.2021.108633_bib0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00018-002-8467-x","article-title":"PPARs: transcriptional effectors of fatty acids and their derivatives","volume":"59","author":"Hihi","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0041","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-010-0533-3","article-title":"Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin","volume":"344","author":"Gentile","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0042","doi-asserted-by":"crossref","first-page":"27971","DOI":"10.1074\/jbc.M111.224352","article-title":"Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes","volume":"286","author":"Chanda","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0043","doi-asserted-by":"crossref","first-page":"26483","DOI":"10.1074\/jbc.M504041200","article-title":"Insig required for sterol-mediated inhibition of Scap\/SREBP binding to COPII proteins in vitro","volume":"280","author":"Sun","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0044","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry","volume":"28","author":"Pulit","year":"2019","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.2347","article-title":"The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism","volume":"17","author":"Lee","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0046","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0047","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Genomes Project","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0048","first-page":"37","article-title":"CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis","author":"Kim","year":"2017","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0049","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.livres.2017.11.002","article-title":"Interaction between stress responses and circadian metabolism in metabolic disease","volume":"1","author":"Yang","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0050","first-page":"37","article-title":"HRD1-ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination","author":"Wei","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0051","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the Physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0052","doi-asserted-by":"crossref","first-page":"27938","DOI":"10.1038\/srep27938","article-title":"CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis","volume":"6","author":"Park","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0053","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0054","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3892\/mmr.2015.4749","article-title":"bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review)","volume":"13","author":"Wang","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0055","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0056","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00125-012-2771-2","article-title":"cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis","volume":"56","author":"Min","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0057","doi-asserted-by":"crossref","DOI":"10.2337\/db16-0298","article-title":"CREBH Couples Circadian Clock with Hepatic Lipid Metabolism","author":"Zheng","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0058","doi-asserted-by":"crossref","first-page":"38041","DOI":"10.1074\/jbc.M112.377978","article-title":"Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene","volume":"287","author":"Chanda","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0059","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11894-003-0005-y","article-title":"Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis","volume":"5","author":"Chitturi","year":"2003","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0060","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0061","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.metabol.2012.06.008","article-title":"High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice","volume":"62","author":"Tsuchiya","year":"2013","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0062","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.1176639","article-title":"ER stress controls iron metabolism through induction of hepcidin","volume":"325","author":"Vecchi","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0063","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmet.2009.01.009","article-title":"Drosophila HNF4 regulates lipid mobilization and beta-oxidation","volume":"9","author":"Palanker","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0064","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review","volume":"13","author":"Grygiel-Gorniak","year":"2014","journal-title":"Nutr J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.coph.2004.11.004","article-title":"Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy","volume":"5","author":"Chinetti-Gbaguidi","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0066","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0067","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tibs.2008.02.002","article-title":"Choose your partners: dimerization in eukaryotic transcription factors","volume":"33","author":"Amoutzias","year":"2008","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0068","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0069","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0070","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0071","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0072","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biochi.2004.11.010","article-title":"Phosphorylation of PPARs: from molecular characterization to physiological relevance","volume":"87","author":"Diradourian","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0073","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/an.111.001602","article-title":"Mechanisms of gene regulation by fatty acids","volume":"3","author":"Georgiadi","year":"2012","journal-title":"Adv Nutr"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0074","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1097-2765(00)80467-0","article-title":"Molecular recognition of fatty acids by peroxisome proliferator-activated receptors","volume":"3","author":"Xu","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: fatty acid sensors controlling metabolism","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0076","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0077","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0078","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2005.04.002","article-title":"\"New\" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis","volume":"1","author":"Chakravarthy","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0079","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1128\/MCB.00370-09","article-title":"Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver","volume":"29","author":"Sanderson","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","article-title":"Modulation of PPAR activity via phosphorylation","volume":"1771","author":"Burns","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0081","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1074\/jbc.274.15.10505","article-title":"Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain","volume":"274","author":"Juge-Aubry","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0082","doi-asserted-by":"crossref","first-page":"37254","DOI":"10.1074\/jbc.M110598200","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes","volume":"277","author":"Blanquart","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0083","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1111\/j.1476-5381.2011.01727.x","article-title":"Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARalpha in rats fed a high-fat diet","volume":"165","author":"Kou","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0084","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0085","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1021\/bi050721g","article-title":"Vanden Heuvel JP. Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C","volume":"44","author":"Gray","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0086","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3beta Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) alpha","volume":"291","author":"Hinds","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0087","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbrc.2008.04.100","article-title":"PPARalpha gene expression is up-regulated by LXR and PXR activators in the small intestine","volume":"371","author":"Inoue","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0088","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","article-title":"Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis","volume":"21","author":"Hayhurst","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0089","first-page":"1013","article-title":"Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element","volume":"16","author":"Pineda Torra","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0090","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/en.2014-1113","article-title":"Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes","volume":"155","author":"Nakagawa","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0091","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1172\/JCI39019","article-title":"Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice","volume":"119","author":"Leuenberger","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0092","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1074\/jbc.M109.078311","article-title":"SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR","volume":"285","author":"Pourcet","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0093","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/MCB.06175-11","article-title":"Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites","volume":"32","author":"Boergesen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0094","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/bbrc.1997.6395","article-title":"DNA binding preferences of PPAR alpha\/RXR alpha heterodimers","volume":"233","author":"Castelein","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0095","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/MCB.17.4.2166","article-title":"Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors","volume":"17","author":"DiRenzo","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134996","article-title":"An Ideal PPAR Response Element Bound to and Activated by PPARalpha","volume":"10","author":"Tzeng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0097","first-page":"1743","article-title":"Identification of Novel Ligands and Structural Requirements for Heterodimerization of the Liver X Receptor Alpha","author":"Bedi","year":"2017","journal-title":"Browse all Theses and Dissertations"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0098","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0099","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/250126","article-title":"Coactivators in PPAR-Regulated Gene Expression","volume":"2010","author":"Viswakarma","year":"2010","journal-title":"PPAR Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0101","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1155\/2007\/26839","article-title":"Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling","volume":"2007","author":"Rakhshandehroo","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0102","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular Actions of PPARalpha in Lipid Metabolism and Inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0103","doi-asserted-by":"crossref","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0026-0495(77)90128-7","article-title":"Laboratory animals exhibiting obesity and diabetes syndromes","volume":"26","author":"Herberg","year":"1977","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700028","article-title":"Alteration of Liver Peroxisomal and Mitochondrial Functionality in the NZO Mouse Model of Metabolic Syndrome","volume":"12","author":"Knebel","year":"2018","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0106","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","article-title":"Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity","volume":"275","author":"Guerre-Millo","year":"2000","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0107","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/diabetes.52.7.1770","article-title":"Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis","volume":"52","author":"Kim","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0108","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1210\/en.2005-1624","article-title":"Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels","volume":"147","author":"Haluzik","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0109","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1746.2011.06939.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis","volume":"27","author":"Larter","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0110","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0111","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI11497","article-title":"PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice","volume":"107","author":"Tordjman","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0112","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2003-1015","article-title":"Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.33549\/physiolres.930744","article-title":"PPAR-alpha and insulin sensitivity","volume":"55","author":"Haluzik","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0114","article-title":"PPARs and Nonalcoholic Fatty Liver Disease","author":"Liss","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of PPARs in NAFLD: potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0116","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","article-title":"Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"273","author":"Aoyama","year":"1998","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0117","doi-asserted-by":"crossref","first-page":"39088","DOI":"10.1074\/jbc.M107073200","article-title":"Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines","volume":"276","author":"Akiyama","year":"2001","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0118","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","article-title":"A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders","volume":"96","author":"Leone","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0119","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20011699","article-title":"Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin","volume":"364","author":"Sugden","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3945\/jn.110.135210","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0121","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/en.2005-1132","article-title":"Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression","volume":"147","author":"Patsouris","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0123","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","author":"Ip","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0124","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jhep.2005.10.033","article-title":"Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates","volume":"44","author":"Shiri-Sverdlov","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0125","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.3748\/wjg.v22.i10.2931","article-title":"Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression","volume":"22","author":"Abd El-Haleim","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0126","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/ATVBAHA.108.179689","article-title":"Fibrates, glitazones, and peroxisome proliferator-activated receptors","volume":"30","author":"Lalloyer","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0127","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/j.amjcard.2006.11.016","article-title":"Safety considerations with fibrate therapy","volume":"99","author":"Davidson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0128","first-page":"19","article-title":"The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development","author":"Hong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0129","first-page":"379","article-title":"W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators","volume":"2","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13543784.2020.1668375","article-title":"Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Westerouen Van Meeteren","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacl.2015.10.012","article-title":"Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial","volume":"10","author":"Bays","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0132","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0133","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0960-894X(01)00188-3","article-title":"Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis","volume":"11","author":"Brown","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0134","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPARalpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00109-005-0678-9","article-title":"Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?","volume":"83","author":"Peters","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0136","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/0008-5472.CAN-04-0322","article-title":"Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0137","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1039\/C6TX00271D","article-title":"Application research on PPARalpha-transgenic mice in preclinical safety evaluation of gemfibrozil","volume":"6","author":"Li","year":"2017","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0138","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plipres.2017.04.002","article-title":"A global perspective on FOXO1 in lipid metabolism and lipid-related diseases","volume":"66","author":"Li","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-019-0938-x","article-title":"The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis","volume":"18","author":"Laissue","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/bj3490629","article-title":"Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues","volume":"349","author":"Furuyama","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0141","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrm2190","article-title":"Stressing the role of FoxO proteins in lifespan and disease","volume":"8","author":"van der Horst","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0142","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/ars.2010.3419","article-title":"The extending network of FOXO transcriptional target genes","volume":"14","author":"van der Vos","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0143","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2337\/db11-0548","article-title":"FoxO6 integrates insulin signaling with gluconeogenesis in the liver","volume":"60","author":"Kim","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0144","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4161\/cc.4.7.1796","article-title":"Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins","volume":"4","author":"Vogt","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0145","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","article-title":"FoxOs at the crossroads of cellular metabolism, differentiation, and transformation","volume":"117","author":"Accili","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0146","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.278.5341.1319","article-title":"daf-16: An HNF-3\/forkhead family member that can function to double the life-span of Caenorhabditis elegans","volume":"278","author":"Lin","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0147","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/40194","article-title":"The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans","volume":"389","author":"Ogg","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0148","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1073\/pnas.0400093101","article-title":"Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification","volume":"101","author":"Hosaka","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0149","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1101\/gad.208926.112","article-title":"FoxO6 regulates memory consolidation and synaptic function","volume":"26","author":"Salih","year":"2012","journal-title":"Genes & development"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0151","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/emboj\/21.9.2263","article-title":"Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion","volume":"21","author":"Rena","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0152","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1126\/science.1130512","article-title":"CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage","volume":"314","author":"Huang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167869","article-title":"Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK\/FoxO1 Pathway","volume":"11","author":"Weng","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0154","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(04)00126-6","article-title":"Mammalian SIRT1 represses forkhead transcription factors","volume":"116","author":"Motta","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030702","article-title":"Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone","volume":"9","author":"Kodani","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0156","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbrc.2009.01.014","article-title":"Acetylation curtails nucleosome binding, not stable nucleosome remodeling, by FoxO1","volume":"379","author":"Hatta","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0157","doi-asserted-by":"crossref","first-page":"20589","DOI":"10.1074\/jbc.M412357200","article-title":"Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes","volume":"280","author":"Frescas","year":"2005","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0158","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010184","article-title":"A Review of FoxO1-Regulated Metabolic Diseases and Related Drug Discoveries","volume":"9","author":"Peng","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0159","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bone.2011.06.034","article-title":"FoxO1, the transcriptional chief of staff of energy metabolism","volume":"50","author":"Kousteni","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0160","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0161","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1677\/jme.0.0300253","article-title":"Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16","volume":"30","author":"Imae","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0162","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1262-3636(07)70133-7","article-title":"Role of the liver in the control of carbohydrate and lipid homeostasis","volume":"30","author":"Postic","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0163","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0164","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1038\/sj.emboj.7601784","article-title":"Foxo1 links insulin signaling to C\/EBPalpha and regulates gluconeogenesis during liver development","volume":"26","author":"Sekine","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0166","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","article-title":"Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors","volume":"5","author":"Haeusler","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0167","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.09.045","article-title":"Selective Inhibition of FOXO1 Activator\/Repressor Balance Modulates Hepatic Glucose Handling","volume":"171","author":"Langlet","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0168","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0169","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1152\/ajpendo.00157.2006","article-title":"PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1","volume":"292","author":"Qu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0170","first-page":"2347","article-title":"FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice","volume":"118","author":"Kamagate","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0171","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/db05-0705","article-title":"Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action","volume":"55","author":"Samuel","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0172","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2337\/db08-1001","article-title":"FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue","volume":"58","author":"Kim","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0173","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/mol.110.065714","article-title":"Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db\/db mice","volume":"78","author":"Nagashima","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0174","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.4161\/15384101.2014.965977","article-title":"Targeting FoxO1 with AS1842856 suppresses adipogenesis","volume":"13","author":"Zou","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2010.07.018","article-title":"Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db\/db mice","volume":"645","author":"Tanaka","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0176","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.semcancer.2017.07.007","article-title":"Role of Forkhead Box Class O proteins in cancer progression and metastasis","volume":"50","author":"Kim","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"Suppl 1","key":"10.1016\/j.jnutbio.2021.108633_bib0177","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jgh.12021","article-title":"Forkhead box class O transcription factors in liver function and disease","volume":"28","author":"Tikhanovich","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0178","first-page":"2464","article-title":"Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism","volume":"116","author":"Matsumoto","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0179","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.M600272200","article-title":"FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression","volume":"281","author":"Zhang","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nm.2686","article-title":"Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1","volume":"18","author":"Lu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0181","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0182","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0183","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0184","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.livres.2017.11.004","article-title":"FOXO transcription factors in non-alcoholic fatty liver disease","volume":"1","author":"Dong","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0185","first-page":"2473","article-title":"The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity","volume":"116","author":"Nakae","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0186","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/ars.2010.3253","article-title":"Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes","volume":"14","author":"Redman","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0187","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/jcm3031050","article-title":"Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease","volume":"3","author":"Yu","year":"2014","journal-title":"J Clin Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0188","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ajcn\/78.3.361","article-title":"Calorie restriction and aging: review of the literature and implications for studies in humans","volume":"78","author":"Heilbronn","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0189","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/oby.2008.201","article-title":"Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function","volume":"16","author":"Larson-Meyer","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2010.11.120","article-title":"Caloric restriction decreases ER stress in liver and adipose tissue in ob\/ob mice","volume":"404","author":"Tsutsumi","year":"2011","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0191","doi-asserted-by":"crossref","first-page":"30111","DOI":"10.1038\/srep30111","article-title":"Caloric restriction of db\/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0192","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/zeb.2011.0702","article-title":"Fasted zebrafish mimic genetic and physiological responses in mammals: a model for obesity and diabetes?","volume":"8","author":"Craig","year":"2011","journal-title":"Zebrafish"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0193","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4093\/dmj.2014.38.4.245","article-title":"FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases","volume":"38","author":"Kim","year":"2014","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0194","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3748\/wjg.v21.i4.1099","article-title":"Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease","volume":"21","author":"Qiu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2004.03.011","article-title":"Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha","volume":"220","author":"Kim","year":"2004","journal-title":"Molecular and cellular endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0196","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4142\/jvs.2004.5.4.325","article-title":"Transactivation of peroxisome proliferator-activated receptor alpha by green tea extracts","volume":"5","author":"Lee","year":"2004","journal-title":"J Vet Sci"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0197","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1017\/S0007114507862386","article-title":"Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs","volume":"99","author":"Serisier","year":"2008","journal-title":"The British journal of nutrition"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0198","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/japtr.JAPTR_116_19","article-title":"Beneficial effects of green coffee and green tea extract combination on metabolic syndrome improvement by affecting AMPK and PPAR-alpha gene expression","volume":"11","author":"Lukitasari","year":"2020","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0199","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/01.hjh.0000544393.97442.09","article-title":"28 GREEN TEA EXTRACT ADMINISTRATION HAD A BENEFICIAL EFFECT ON PPAR ALPHA AND PPAR GAMMA GENE EXPRESSION IN METABOLIC SYNDROME RAT MODEL","volume":"36","author":"Lukitasari","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11010-018-3324-x","article-title":"Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1\/FOXO1 signaling pathway","volume":"448","author":"Li","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0201","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/acs.jafc.9b00395","article-title":"Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1","volume":"67","author":"Li","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"European journal of nutrition"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0203","article-title":"Epigallocatechin-3-Gallate (EGCG)-Inducible SMILE Inhibits STAT3-Mediated Hepcidin Gene Expression","volume":"9","author":"Kim","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0204","doi-asserted-by":"crossref","first-page":"41972","DOI":"10.1074\/jbc.M111.274514","article-title":"Curcumin differentially regulates endoplasmic reticulum stress through transcriptional corepressor SMILE (small heterodimer partner-interacting leucine zipper protein)-mediated inhibition of CREBH (cAMP responsive element-binding protein H)","volume":"286","author":"Misra","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0205","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways","volume":"24","author":"Ren","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0206","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jfda.2018.01.005","article-title":"Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells","volume":"26","author":"Chen","year":"2018","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0207","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1210\/en.2008-0262","article-title":"Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity","volume":"149","author":"Weisberg","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0208","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5662\/wjm.v6.i1.112","article-title":"Potential effects of curcumin on peroxisome proliferator-activated receptor-gamma in vitro and in vivo","volume":"6","author":"Mazidi","year":"2016","journal-title":"World J Methodol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0209","first-page":"1","article-title":"Effects of dietary curcumin on growth, antioxidant capacity, fatty acid composition and expression of lipid metabolism-related genes of large yellow croaker fed a high-fat diet","author":"Ji","year":"2020","journal-title":"The British journal of nutrition"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0007114519001508","article-title":"Curcumin attenuates insulin resistance and hepatic lipid accumulation in a rat model of intra-uterine growth restriction through insulin signalling pathway and sterol regulatory element binding proteins","volume":"122","author":"Niu","year":"2019","journal-title":"The British journal of nutrition"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/1751-2980.12610","article-title":"Fatty liver mediated by peroxisome proliferator-activated receptor-alpha DNA methylation can be reversed by a methylation inhibitor and curcumin","volume":"19","author":"Li","year":"2018","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0212","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/mnfr.201100440","article-title":"Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism","volume":"55","author":"Shin","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0213","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1159\/000495898","article-title":"Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1\/ATF6-Dependent Mechanism","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0214","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1128\/MCB.00665-15","article-title":"Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism","volume":"35","author":"Kim","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0215","doi-asserted-by":"crossref","first-page":"C411","DOI":"10.1152\/ajpcell.00095.2007","article-title":"Vaticanol B, a resveratrol tetramer, regulates endoplasmic reticulum stress and inflammation","volume":"293","author":"Tabata","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0216","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/cbic.201300754","article-title":"Resveratrol and its metabolites bind to PPARs","volume":"15","author":"Calleri","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0217","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.apsb.2017.05.005","article-title":"The potential of natural products for targeting PPARalpha","volume":"7","author":"Rigano","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0218","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s10529-012-1034-0","article-title":"Resveratrol prevents hepatic steatosis induced by hepatitis C virus core protein","volume":"34","author":"Jiang","year":"2012","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0219","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1139\/apnm-2019-0057","article-title":"Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARalpha pathway","volume":"45","author":"Huang","year":"2020","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0220","article-title":"Resveratrol Attenuates High-Fat Diet Induced Hepatic Lipid Homeostasis Disorder and Decreases m6A RNA Methylation","author":"Wu","year":"2020","journal-title":"Research Square"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0221","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2009.01.163","article-title":"Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway","volume":"380","author":"Wang","year":"2009","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0222","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2010.11.028","article-title":"Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver","volume":"403","author":"Park","year":"2010","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0223","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1111\/febs.12949","article-title":"AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1","volume":"281","author":"Yun","year":"2014","journal-title":"The FEBS journal"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0224","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-11-35","article-title":"Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice","volume":"11","author":"Zhu","year":"2014","journal-title":"Nutrition & metabolism"},{"key":"10.1016\/j.jnutbio.2021.108633_bib0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111877","article-title":"Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome","volume":"17","author":"de la Iglesia","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095528632100053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095528632100053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:32:35Z","timestamp":1760628755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095528632100053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":225,"alternative-id":["S095528632100053X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108633","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108633"}}